Endoscopy remains the reference standard for the diagnosis and assessment of patients
with inflammatory bowel disease (IBD), but it has several important limitations. Cross …

Abstract Background and Aims No consensus exists on defining intestinal ultrasound
response, transmural healing, or transmural remission in inflammatory bowel disease, nor …

Treatment targets of inflammatory bowel diseases (IBD), ulcerative colitis (UC) and Crohn's
disease (CD) have evolved over the last decade. Goals of therapy consisting of symptom …

Intestinal ultrasound (IUS) is a non‐invasive and accurate tool to assess inflammatory bowel
disease. The ECCO‐ESGAR guideline recommends the use of IUS for the assessment of …

Breaking through the biologic therapy efficacy plateau for inflammatory bowel disease
requires the strategic development of personalized biomarkers in the tight control model …

Introduction With the expanding therapeutic armamentarium for inflammatory bowel disease
(IBD), real-world data may help inform drug positioning. We assessed clinical, endoscopic …

Background: Intestinal ultrasound is emerging as a non-invasive tool for monitoring disease
activity in inflammatory bowel disease patients due to its low cost, excellent safety profile …

Aim: To evaluate the value of abdominal ultrasonography (US) in the follow-up of paediatric
patients with ulcerative colitis (UC) compared to faecal calprotectin (FC) and colonoscopy …

Background & aims Transmural healing is a long-term target for patients with Crohn's
disease. Factors contributing to its promotion are poorly understood. This study assessed …

The FutureIBD meeting in Barcelona, Spain, was the first time that leading
gastroenterologists had been able to meet face-to-face for quite some time due to the …